Free Content Post-operative Blood Salvage and Retransfusion in Total Hip and Knee Arthroplasty

Authors: Athanasoulias, V.; Mavrogenis, A.F.; Sdrenias, C.V.; Mitsiokapa, E.A.; Lourikas, V.; Papagelopoulos, P.J.; Christodoulou, N.A.

Source: The Journal of International Medical Research, Volume 35, Number 2, March 2007 , pp. 268-275(8)

Publisher: Field House Publishing

Buy & download fulltext article:

Free content The full text is free.

View now:
PDF 150.3kb 

Abstract:

This retrospective study evaluated the safety and efficacy of post-operative blood salvage and retransfusion in 430 patients undergoing total hip arthroplasty and 530 patients undergoing total knee arthroplasty. Volumes of autologous blood retransfused (mean ± SD) were 525 ± 75 and 660 ± 95 ml in the hip and knee replacement groups, respectively. Overall, 230 patients (24%) also required allogeneic blood transfusion. In a subgroup of 150 randomly selected patients, the values of free haemoglobin in the allogeneic, autologous and patients' blood at the time of surgery were 0.568 ± 0.112, 0.272 ± 0.067 and 0.032 ± 0.011 g/l, respectively. On the first and third post-operative days, the levels in patients' blood were 0.092 ± 0.039 and 0.057 ± 0.028 g/l, respectively. There were no major complications; transient chills and fever were reported in 99 (10.3%) and 115 patients (12.0%), respectively. In conclusion, post-operative blood salvage and retransfusion is a safe way to reduce the need for allogeneic blood transfusion in patients undergoing elective orthopaedic surgery.

Keywords: AUTOTRANSFUSION; JOINT ARTHROPLASTY; BLOOD SALVAGE; ALLOGENEIC TRANSFUSION

Document Type: Case report

Affiliations: 1: Department of Anaesthesiology, General Hospital of Karpenissi, Evrytania, Greece

Publication date: 2007-03-01

More about this publication?
  • The Journal of International Medical Research (JIMR) is a leading peer reviewed journal offering exceptional publication speed for medical, clinical and pre-clinical research. Reviews, case studies, preliminary communications, post-marketing surveillance, pharmacoeconomic and managed care studies are also welcome. Supplements publish symposium proceedings or collections of medical, pre-clinical or clinical data and enquiries from potential sponsors are welcome. JIMR is widely indexed and abstracted, including Medline, Current Contents and Excerpta Medica (EMBASE).
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • ingentaconnect is not responsible for the content or availability of external websites

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page